MedTrace Logo

Magnetic Stimulation Therapy for Treating Vascular Depression

NCT00044798 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2013-09-27

No results posted yet for this study

Summary

This 12-week study will evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) of the brain, followed by citalopram (Celexa®), for treatment of depression associated with small vascular lesions in the brain (vascular depression).

Conditions

Interventions

PROCEDURE

Repetitive transcranial magnetic stimulation (rTMS)

Participants will receive 15 treatments of rTMS over 3 weeks.

DRUG

Citalopram

After completing treatment with rTMS or sham rTMS, participants will take citalopram for 9 weeks.

PROCEDURE

Sham rTMS

Participants will receive 15 treatments of sham rTMS over 3 weeks.

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of Iowa

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
51 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-09-30
Primary Completion
2007-03-31
Completion
2008-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00044798 on ClinicalTrials.gov